[Bone marrow biopsy in myeloproliferative syndromes: prognostic value of cellular quantification].
The proportion of granulocytes, erythroblasts, immature cells and megakaryocytes was evaluated when revising the bone-marrow biopsy specimens of 36 patients with myeloproliferative syndromes. These proportions were compared between themselves, a so-called Z value being thus attained; such value resulted from summing the proportion of granulocytes, megakaryocytes and immature cells and subtracting the proportion of erythroblasts. According to its value, above or below the mean, the Z figure correlates with the survival, the difference between both groups appearing as statistically significant (p = 0.02).
Esquivias López-Cuervo
J J
JJ
Servicio de Anatomía Patológica, Ciudad Sanitaria Virgen de las Nieves, Granada.
Romero Aguilar
A
A
González García
J
J
D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology*; D001856:Bone Marrow Examination; D002452:Cell Count; D005069:Evaluation Studies as Topic; D006801:Humans; D015993:Life Tables; D009196:Myeloproliferative Disorders / Q000401:mortality / Q000473:pathology*; D011379:Prognosis; D013030:Spain / Q000453:epidemiology; D015996:Survival Rate
Biopsia medular en los síndromes mieloproliferativos: valor pronóstico de la cuantificación celular.